Titolo |
Pubblicato in |
Anno |
Impact of tumor site on the prognosis of small bowel adenocarcinoma |
TUMORI |
2019 |
CAR-T with License to Kill Solid Tumors in Search of a Winning Strategy |
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES |
2019 |
Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: a real-world experience |
JOURNAL OF CELLULAR PHYSIOLOGY |
2019 |
A nomogram to predict survival in non-small cell lung cancer patients treated with nivolumab |
JOURNAL OF TRANSLATIONAL MEDICINE |
2019 |
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting |
INTERNATIONAL JOURNAL OF CANCER |
2019 |
Clinical impact of highly purified, whey proteins in patients affected with colorectal cancer undergoing chemotherapy: preliminary results of a placebo-controlled study |
INTEGRATIVE CANCER THERAPIES |
2019 |
Early fatigue in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: an insight from clinical practice |
JOURNAL OF TRANSLATIONAL MEDICINE |
2019 |
NUT midline carcinoma: Current concepts and future perspectives of a novel tumour entity |
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY |
2019 |
Drug resistance of BRAF-mutant melanoma: Review of up-to-date mechanisms of action and promising targeted agents |
EUROPEAN JOURNAL OF PHARMACOLOGY |
2019 |
Clinical and psychometric validation of the BreSAS questionnaire module for symptom assessment among breast cancer survivors |
SUPPORTIVE CARE IN CANCER |
2019 |
Electrochemotherapy as Promising Treatment Option in Rare Recurrent Cutaneous Neoplasm of the Scalp: Case Report of an Elderly Patient |
CASE REPORTS IN ONCOLOGICAL MEDICINE |
2019 |
A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: When overweight becomes favorable |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
2019 |
Clinical Outcomes of Patients with Advanced Cancer and Pre-Existing Autoimmune Diseases Treated with Anti-Programmed Death-1 Immunotherapy: A Real-World Transverse Study |
THE ONCOLOGIST |
2019 |
Biliary tract cancer: Current challenges and future prospects |
CANCER MANAGEMENT AND RESEARCH |
2019 |
CD73 expression and pathologic response to neoadjuvant chemotherapy in triple negative breast cancer |
VIRCHOWS ARCHIV |
2019 |
Immunotherapy in non-small cell lung cancer patients: back to the future |
RECENTI PROGRESSI IN MEDICINA |
2019 |
A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: When overweight becomes favorable |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
2019 |
Early fatigue in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: an insight from clinical practice |
JOURNAL OF TRANSLATIONAL MEDICINE |
2019 |
Clinical Impact of Highly Purified, Whey Proteins in Patients Affected With Colorectal Cancer Undergoing Chemotherapy: Preliminary Results of a Placebo-Controlled Study |
|
2019 |
Electrochemotherapy as Promising Treatment Option in Rare Recurrent Cutaneous Neoplasm of the Scalp: Case Report of an Elderly Patient |
CASE REPORTS IN ONCOLOGICAL MEDICINE |
2019 |